Michael Cloonan is of bluebird bio, Inc.. Currently has a direct ownership of 0 shares of BLUE, which is worth approximately $0. The most recent transaction as insider was on Jun 02, 2025, when has been sold 1,867 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Michael Cloonan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2025
SELL
Sale (or disposition) back to the issuer
-
1,867 Reduced 100.0%
0 Common Stock
Sep 30 2024
BUY
Grant, award, or other acquisition
-
37,350 Added 50.0%
37,350 Common Stock

Also insider at

SAGE
Sage Therapeutics, Inc. Healthcare
SION
Sionna Therapeutics, Inc.
MC

Michael Cloonan

Cambridge, MA

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE